HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm

Oncogene

Volumn 33, Issue 18, 2014, Pages 2317-2328

  Mukai, R ^a   Ohshima, T ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

ATL; GADD34; HBZ; HTLV 1; Nuclear export

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 34; HUMAN T CELL LEUKEMIA VIRUS 1 BASIC LEUCINE ZIPPER FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; S6 KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STARVATION; T CELL LEUKEMIA;

HUMAN T-LYMPHOTROPIC VIRUS 1; MAMMALIA;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; AUTOPHAGY; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL NUCLEUS; CYTOPLASM; HEK293 CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; KARYOPHERINS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; NUCLEAR EXPORT SIGNALS; PROTEIN PHOSPHATASE 1; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TOR SERINE-THREONINE KINASES; TRANSFECTION; VIRAL PROTEINS;

EID: 84899989607     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.181     Document Type: Article

References (58)

1. Uchiyama T. Human T cell leukemia virus type I (HTLV-1) and human diseases. Annu Rev Immunol 1997; 15: 15-37.
2. Yasunaga J, Matsuoka M. Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol 2011; 94: 435-442.
3. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983; 80: 3618-3622.
4. Albrecht B, Lairmore MD. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev 2002; 66: 396-406.
5. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475-496.
6. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005; 24: 5931-5937.
7. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005; 24: 5976-5985.
8. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y et al. Thymusderived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 2006; 12: 466-472.
9. Boxus M, Twizere JC, Leqros S, Dewulf JF, Kettmann R, Willems L. The HTLV-1 Tax interactome. Retrovirology 2008; 5: 76.
10. Simonins N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS et al. Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology 2012; 9: 26.
11. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 1996; 88: 3065-3073.
12. Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood 2001; 97: 987-993.
13. Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S et al. 50-Long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol 2002; 76: 9389-9397.
14. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 2004; 109: 559-567.
15. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A et al. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005; 2: 64.
16. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 2002; 76: 12813-12822.
17. Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 2006; 103: 720-725.
18. Rende F, Cavallari I, Corrandin A, Silic-Benussi M, Toulza F, Toulza F et al. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNA. Blood 2011; 117: 4855-4859.
19. Bender C, Rende F, Cotena A, Righi P, Ronzi P, Cavallari I et al. Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA. Retrovirology 2012; 9: 74.
20. Hivin P, Fréderic M, Arpin-AndreC, Basbous J, Gay B, Thébault S et al. Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J Cell Sci 2005; 118: 1355-1362.
21. Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 2003; 278: 43620-43627.
22. Thebault S, Basbous J, Hivin P, Devaux C, Mesnard JM. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett 2004; 562: 165-170.
23. Matsumoto J, Ohshima T, Isono O, Shimotohno K. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 2005; 24: 1001-1010.
24. Matsuoka M, Green PL. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009; 6: 71.
25. Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 2011; 8: 19.
26. Isono O, Ohshima T, Saeki Y, Matsumoto J, Hijikata M, Tanaka K et al. Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination. J Biol Chem 2008; 283: 34273-34282.
27. Chou J, Roizman B. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc Natl Acad Sci USA 1994; 91: 5247-5251.
28. Watanabe R, Tambe Y, Inoue H, Isono T, Haneda M, Isobe K et al. GADD34 inhibits mammalian target of rapamycin signaling via tuberous sclerosis complex and controls cell survival under bioenergetic stress. Int J Mol Med 2007; 19: 475-483.
29. Murata K, Hayashibara T, Sugahara K, Uemura A, Yamaguchi T, Harasawa H et al. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol 2006; 80: 2495-2505.
30. Cavanagh MH, Landry S, Audet B, Arpin-AndreC, Hivin P, PareME et al. HTLV-1 antisense transcripts initiating in the 30LTR are alternatively spliced and polyadenylated. Retrovirology 2006; 3: 15.
31. Yoshida M, Satou Y, Yasunaga J, Fujisawa J, Matsuoka M. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J Virol 2008; 19: 9359-6368.
32. Zhou W, Brush MH, Choy MS, Shenolikar S. Association with endoplasmic reticulum promotes proteasomal degradation of GADD34 protein. J Biol Chem 2011; 256: 21687-21696.
33. Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584: 1287-1295.
34. Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010; 11: 453-465.
35. Uddin MN, Ito S, Nishio N, Suganya T, Isobe K. Gadd34 induces autophagy through the suppression of the mTOR pathway during starvation. Biochem Biophys Res Commun 2011; 407: 692-698.
36. Jiang BH, Liu LZ. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updat 2008; 11: 63-76.
37. Yoshita M, Higuchi M, Takahashi M, Oie M, Tanaka Y, Fujii M. Activation of mTOR by human T-cell leukemia virus type 1 Tax is important for the transformation of mouse T cells to interleukin-2-independent growth. Cancer Sci 2012; 103: 369-374.
38. Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 2011; 10: 868-880.
39. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149: 274-293.
40. Hardt M, Chantaravisoot N, Tamanoi F. Activating mutations of TOR (target of rapamycin). Genes Cells 2011; 16: 141-151.
41. Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M et al. Virus-triggered autophagy in viral hepatitis-possible novel strategies for drug development. J Virol Hepat 2011; 18: 821-830.
42. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990-995.
43. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
44. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
45. Lee HK, Iwasaki A. Autophagy and antiviral immunity. Curr Opin Immunol 2008; 20: 23-29.
46. Taylor MP, Jackson WT. Viruses and arrested autophagosomes development. Autophagy 2009; 5: 870-871.
47. Kudchodkar SB, Levine B. Viruses and autophagy. Rev Med Virol 2009; 19: 359-378.
48. Orvedahl A, Levine B. Autophagy in mammalian antiviral immunity. Curr Top Microbiol Immunol 2009; 335: 267-285.
49. Kirkegaard K. Subversion of the cellular autophagy pathway by viruses. Curr Top Microbiol Immunol 2009; 335: 323-333.
50. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G et al. Protection against fatal Sindbis virus encephalitis by Beclin, a novel Bcl-2-interacting protein. J Virol 1998; 72: 8586-8596.
51. Talloczy Z, Jiang W, Virgin IV HW, Leib DA, Scheuner D, Kaufman RJ et al. Regulation of starvation-and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci USA 2002; 99: 190-195.
52. Orvedahl A, MacPherson S, Sumpter Jr R, Talloczy Z, Zou Z, Levine B. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 2010; 7: 115-127.
53. Chaumorcel M, Souquere S, Pierron G, Codogno P, Esclatine A. Human cytomegalovirus controls a new autophagy-dependent cellular antiviral defense mechanism. Autophagy 2008; 4: 46-54.
54. Chuluubaatar U, Roller R, Feldman ME, Brown S, Shokat KM, Mohr I. Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and Viral replication. Genes Dev 2010; 24: 2627-2639.
55. Harhaj EW, Sun SC. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 1999; 274: 22911-22914.
56. Bex F, Yin MJ, Burny A, Gaynor RB. Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol 1998; 18: 2392-2405.
57. Li J, Liu J, Song J, Wang X, Weiss HL, Townsend Jr CM et al. mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. Am J Physiol Cell Physiol 2011; 301: 213-226.
58. Ohshima T, Mukai R, Nakahara N, Matsumoto J, Isono O, Kobayashi Y et al. HTLV-1 basic leucine-zipper factor, HBZ, interacts with MafB and suppresses transcription through a Maf recognition element. J Cell Biochem 2010; 111: 187-194.